medline.ch Neurologie Multiple Sklerose

	Erratum: Secondary Autoimmune Dermatological Disorders Induced by Multiple Sclerosis Biological Immunotherapy Agents: A Systematic Review of Case Reports [IJ Pharm Res. 2025; 24 (1): e166426]. Iran J Pharm Res Sahraian MA, Emami S, Ataei S, Nasr Esfahani F, Ghalandari N. PMID: 41477121 [PubMed]
	Secondary Autoimmune Dermatological Disorders Induced by Multiple Sclerosis Biological Immunotherapy Agents: A Systematic Review of Case Reports. Iran J Pharm Res Sahraian MA, Emami S, Ataei S, Nasr Esfahani F, Ghalandari N. PMID: 41477116 [PubMed]
	Lower vascular cerebral flow and cerebral perfusion may be associated with impairment of the glymphatic system in multiple sclerosis: A cross-sectional DTI-ALPS MRI study. J Neurol Sci Jakimovski D, Bergsland N, Marr K, Dwyer MG, Tranquille A, Weinstock-Guttman B, Zivadinov R. PMID: 41475065 [PubMed - as supplied by publisher]
	Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study. Ther Adv Neurol Disord Lucchini M, Borriello G, Haggiag S, Nicoletti CG, Fantozzi R, Buscarinu MC, Ferrazzano G, Cortese A, Marinelli F, Monteleone F, Centonze D, Conte A, Ferraro E, Gasperini C, Marfia GA, Pozzilli C, Salvetti M, Barbuti E, Bellucci G, Bianco A, Carlomagno V, Cruciani A, De Giglio L, Dionisi C, Ianniello A, Malimpensa L, Nasello M, Nociti V, Prosperini L, Tortorella C, Mirabella M. PMID: 41472694 [PubMed]
	Assessment of the RoAD Score as a Predictor of Long-Term Irreversible Ambulatory Disability in Multiple Sclerosis: Evidence from a Real-World Cohort. Medicina (Kaunas) Guerra T, Esposto C, Limitone S, Paolicelli D, Iaffaldano P. PMID: 41470123 [PubMed - indexed for MEDLINE]
	CAR T cells as novel therapeutic strategy for multiple sclerosis and other neuroimmune disorders. J Neuroinflammation Samadzadeh S, Szejko N, Hamadah Y, Tan WY, Gluscevic S, Boldrini V, Ricigliano VAG, Hartung HP, Montalban X, ECF Young Investigators/Fellows Initiative. PMID: 41470000 [PubMed - as supplied by publisher]
	T1-weighted subtraction maps improve the detection of contrast-enhancing lesions in multiple sclerosis. Eur J Radiol Beyrle M, Sepp D, Eichinger P, Mühlau M, Berthele A, Engl C, Hemmer B, Zimmer C, Wiestler B, Kirschke JS, Kertels O. PMID: 41468656 [PubMed - as supplied by publisher]
	Multiple sclerosis expert patient program in Central America: changes in quality of life and lifestyle habits. Neurodegener Dis Manag Arrighi E, Navas C, Vázquez N, León AP, Casillas PA, Cabrera MC, Echandi G, Arambu ZD, Salgado MR, Cruz RM. PMID: 41467296 [PubMed - as supplied by publisher]
	Global burden and epidemiological trends of paediatric-onset multiple sclerosis: a cross-sectional analysis of the 2021 global burden of disease study. Front Pediatr Zhuo Z, Zhao Z, Yan M, Tan J, Gu Y, Zhong W, Zhang Y, Liu H. PMID: 41467155 [PubMed]
	Overexpression of ITGB3 in Peripheral Blood Mononuclear Cells of Relapsing-Remitting Multiple Sclerosis Patients. Int J Mol Sci Sancho GBV, Buendia-Corona RE, Reyes-Mata MP, Mireles-Ramírez MA, Griñán-Ferré C, Pallàs M, Márquez-Aguirre AL, Pavon L, Arias-Carrión O, Guerrero-García JJ, Ortuño-Sahagún D. PMID: 41465519 [PubMed - indexed for MEDLINE]
	Diroximel Fumarate-Loaded Solid Lipid Nanoparticles (DRF-SLNs) as Potential Carriers for the Treatment of Multiple Sclerosis: Preformulation Study. Int J Mol Sci Santonocito D, Greco G, Sarpietro MG, Schoubben A, Sciacca C, Romeo G, Mangano K, Puglia C. PMID: 41465257 [PubMed - indexed for MEDLINE]
	GFAP, CHI3L1 and GCIPL Thickness as Baseline Predictors of Early Disability Progression in MS. Int J Mol Sci Enache II, Tiu VE, Anghel CA, Tiu C, Popa-Cherecheanu A, Bostan M, Scippa S, Balestrieri A, Smaldone G, Soricelli A. PMID: 41465206 [PubMed - indexed for MEDLINE]
	Superiority of 3D-DIR over 3D-FLAIR in the Detection of Cortical Lesions and Correlation with Disability in Multiple Sclerosis: A Multicenter Study. Diagnostics (Basel) Grazzini I, Del Roscio D, Cirinei M, Calchetti B, Grammatico M, Spossati G, Malatesti L, De Stefano T, Cuneo A, Leonini S, Piane E, Testaverde L. PMID: 41464105 [PubMed]
	Energy-Metabolic Imbalance of Oligodendrocytes in Multiple Sclerosis: Mechanisms, Network Coupling, and Advances in Metabolism-Targeted Therapies. Biomedicines Zhang Z, Kang J, Guo X, Jiang T, Li X. PMID: 41462894 [PubMed]
	Burden of comorbidities in people with multiple sclerosis: a population-based study in Catalonia. Front Neurol Mora T. PMID: 41458116 [PubMed]
	Occupational balance, quality of life, occupational performance, and disease-related factors in people with multiple sclerosis: A case-control study. Aust Occup Ther J Ortiz-Rubio A, Lexell EM, Håkansson C, Navas-Otero A. PMID: 41457374 [PubMed - indexed for MEDLINE]
	First molecular identification and genetic diversity of Giardia duodenalis and Blastocystis sp. in patients with multiple sclerosis in Iran. Mol Biol Rep Shafiee M, Modiri L, Khademerfan M, Bahrami F. PMID: 41456244 [PubMed - indexed for MEDLINE]
	Is newly diagnosed multiple sclerosis a medical emergency? Mult Scler Relat Disord El Mouhajir H, Alrashed A, Mohamed B, Schmierer K. PMID: 41455295 [PubMed - as supplied by publisher]
	Optimizing kappa free light chain index thresholds for multiple sclerosis (MS) diagnosis in low-MS prevalence regions: Insights from an Asian cohort. Mult Scler Kim SH, Kang YR, Chung J, Joo M, Payumo RMP, Kim KH, Hyun JW, Kim HJ. PMID: 41454730 [PubMed - as supplied by publisher]
	Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial. Mult Scler Calabresi PA, Giovannoni G, Hartung HP, Naismith RT, Fox RJ, Sormani MP, Arnold DL, Kappos L, Valis M, Newsome SD, Belkin MI, Bartholomé E, Riester K, Javor A, Lyons J, Bradley DP, Fisher E, Tagge I, Naylor ML, Belachew S, Deykin A, Franchimont N, Zhu B, Cheng W. PMID: 41454463 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 43017

Seite 1 von 2151

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung